MENU

These ASX shares are down over 50% in 2018

Yesterday I looked at three ASX shares that had vastly outperformed the All Ordinaries (Index: ^AXAO) (ASX: XAO) in 2018 with gains of over 50%.

Today I thought I would look at the shares that had gone the other way. Three that have fallen more than 50% this year are listed below:

The Bionomics Ltd (ASX: BNO) share price has crashed 71.5% lower since the start of the year. Investors were hitting the sell button in a hurry at the end of September after the biotech company announced disappointing results from the phase 2 clinical trial of its BNC210 novel drug candidate in patients with Post Traumatic Stress Disorder (PTSD). The trial did not meet its primary endpoint of a decrease in PTSD symptoms as measured by Clinician-Administered PTSD Scale at 12 weeks. As BNC210 had a lot of promise and was the main attraction to the company for most investors, this news has been a bitter blow.

The BWX Ltd (ASX: BWX) share price has dropped a massive 60% so far in 2018. The main catalyst for this decline was the withdrawal of a takeover approach from the Bain consortium. But in addition to this, the sudden slowing of sales of its key Sukin brand and the disappointing performance of its acquisitions has weighed heavily on its shares this year. While its shares do look reasonable value, I’m holding off an investment until I’ve seen a big improvement in its performance.

The Integrated Research Limited (ASX: IRI) share price has plunged 57% lower this year. The global provider of proactive experience management solutions for critical IT infrastructure, payments and communications ecosystems has been a consistently strong performer over the last decade. But all that came to an end this year after a surprisingly poor FY 2018 result. In addition to this, the surprise resignation of its CEO has weighed on investor sentiment. While I think that Integrated Research is a quality company, I feel it would be best to stay clear of its shares until there are signs that it has moved on from this difficult period.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked…

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of The Motley Fool’s Top 3 Blue Chip Stocks for 2019.

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in a specially prepared FREE report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

See the 3 blue chip stocks

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BWX Limited. The Motley Fool Australia has recommended Integrated Research Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.